SCHEMBL7297873

SCHEMBL7297873

CN(C)CCCN(C(=O)CCc1ccccc1)c1ccccc1SCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 6/20 0.67
MAPT P10636 4/20 0.48
MAPK1 P28482 3/20 0.48
GAA P10253 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MITF O75030 1/20 0.47
LMNA P02545 1/20 0.47
IDE P14735 1/20 0.47
HTT P42858 1/20 0.47
TP53 P04637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KMT2A Q03164 1/20 0.44
ALOX5 P09917 2/20 0.43
SIGMAR1 Q99720 1/20 0.41
MLYCD O95822 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7290248 0.89 NPY2R (0.69) NPY2RMAPTMAPK1GAASMN1; SMN2
SCHEMBL7290404 0.88 NPY2R (0.65) NPY2RMAPTMAPK1GAATP53
Oxalic Acid SCHEMBL7291345 0.85 NPY2R (0.63) NPY2RMAPTSMN1; SMN2KMT2ASIGMAR1
SCHEMBL7290237 0.84 NPY2R (0.69) NPY2RKMT2ASIGMAR1
SCHEMBL7290591 0.83 NPY2R (0.61) NPY2RMAPK1GAASMN1; SMN2TP53
SCHEMBL7288694 0.83 NPY2R (0.61) NPY2RMAPK1GAASMN1; SMN2TP53
SCHEMBL9736030 0.82 NPY2R (0.59) NPY2RMAPTGAASMN1; SMN2KMT2A
SCHEMBL7298617 0.82 NPY2R (0.59) NPY2RMAPTGAASMN1; SMN2KMT2A
SCHEMBL7288507 0.81 NPY2R (0.58) NPY2RSMN1; SMN2KMT2AALOX5
Hydrochloric Acid SCHEMBL7291470 0.81 NPY2R (0.60) NPY2RMAPTMAPK1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116851-A Administering antiischemic and antiarrhythmia agents E. R. SQUIBB & SONS, INC. (US) 1992-05-26 US claimed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP claimed
US-5116851-A Administering antiischemic and antiarrhythmia agents E. R. SQUIBB & SONS, INC. (US) 1992-05-26 US disclosed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP disclosed